• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

On the Proposed Definition of Metabolic-Associated Fatty Liver Disease.

作者信息

Wai-Sun Wong Vincent, Kanwal Fasiha

机构信息

Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

Professor of Medicine, Chief, Gastroenterology and Hepatology, Sections of Gastroenterology and Hepatology, Health Services Research, Department of Medicine, Baylor College of Medicine, VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.

出版信息

Clin Gastroenterol Hepatol. 2021 May;19(5):865-870. doi: 10.1016/j.cgh.2021.01.017. Epub 2021 Jan 13.

DOI:10.1016/j.cgh.2021.01.017
PMID:33453398
Abstract
摘要

相似文献

1
On the Proposed Definition of Metabolic-Associated Fatty Liver Disease.关于代谢相关脂肪性肝病的拟议定义。
Clin Gastroenterol Hepatol. 2021 May;19(5):865-870. doi: 10.1016/j.cgh.2021.01.017. Epub 2021 Jan 13.
2
Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes".关于“非酒精性脂肪性肝病：定义与亚型”的信函
Clin Mol Hepatol. 2023 Jul;29(3):810-811. doi: 10.3350/cmh.2023.0129. Epub 2023 May 8.
3
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology.将术语从非酒精性脂肪性肝病改为代谢功能障碍相关脂肪性肝病，这不仅仅是术语的改变。
Clin Mol Hepatol. 2023 Apr;29(2):371-373. doi: 10.3350/cmh.2023.0086. Epub 2023 Mar 14.
4
The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome.非酒精性脂肪性肝病、结肠憩室病与代谢综合征之间的相互关系
J Gastrointestin Liver Dis. 2021 Jun 18;30(2):274-282. doi: 10.15403/jgld-3308.
5
Psoriasis and non-alcoholic fatty liver disease.银屑病与非酒精性脂肪性肝病
J Dtsch Dermatol Ges. 2021 Apr;19(4):503-504. doi: 10.1111/ddg.14469.
6
Non-alcoholic fatty liver disease: What's in our arsenal?非酒精性脂肪性肝病：我们有哪些可用的方法？
J Fam Pract. 2016 Apr;65(4):239-44.
7
Overdiagnosis of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的过度诊断
Am Fam Physician. 2022 Dec;106(6):704-707.
8
The Future of Nonalcoholic Fatty Liver Disease Treatment.非酒精性脂肪性肝病治疗的未来。
Med Clin North Am. 2019 Jan;103(1):57-69. doi: 10.1016/j.mcna.2018.08.005. Epub 2018 Nov 1.
9
Metabolic fatty liver syndromes: where do we stand in 2024?代谢性脂肪性肝病综合征：2024年我们处于什么位置？
J Gastroenterol Hepatol. 2024 Apr;39(4):613-614. doi: 10.1111/jgh.16507. Epub 2024 Feb 15.
10
Non-alcoholic fatty liver disease and cardiovascular risk: an update.非酒精性脂肪性肝病与心血管风险：最新进展
Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1175-1177. doi: 10.1080/17474124.2018.1533117. Epub 2018 Oct 16.

引用本文的文献

1
Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective.非酒精性脂肪性肝病的无创诊断：现状与未来展望。
Heliyon. 2024 Feb 29;10(5):e27325. doi: 10.1016/j.heliyon.2024.e27325. eCollection 2024 Mar 15.
2
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.代谢功能障碍相关脂肪性肝病与肝细胞癌风险
JHEP Rep. 2023 Jun 28;5(9):100810. doi: 10.1016/j.jhepr.2023.100810. eCollection 2023 Sep.
3
Transition patterns of metabolic dysfunction-associated fatty liver disease status in relation to arterial stiffness progression: a health check-up cohort study.
代谢相关脂肪性肝病与动脉僵硬度进展相关的状态转变模式：一项健康检查队列研究。
Sci Rep. 2023 Jun 15;13(1):9690. doi: 10.1038/s41598-023-35733-0.
4
Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy.代谢相关脂肪性肝病患者的长期临床转归：一项基于基线肝活检的单中心前瞻性队列研究。
Hepatol Int. 2023 Aug;17(4):870-881. doi: 10.1007/s12072-023-10550-9. Epub 2023 May 26.
5
Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease.探究代谢表型对酒精性和非酒精性脂肪性肝病健康事件的影响。
J Clin Transl Hepatol. 2023 Jun 28;11(3):525-533. doi: 10.14218/JCTH.2022.00214. Epub 2023 Jan 4.
6
Risk of subclinical atherosclerosis across metabolic transition in individuals with or without fatty liver disease: a prospective cohort study.患有或未患有脂肪肝疾病的个体在代谢转变过程中亚临床动脉粥样硬化的风险：一项前瞻性队列研究
Nutr Metab (Lond). 2023 Mar 10;20(1):15. doi: 10.1186/s12986-023-00734-3.
7
Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis.专家小组对描述用于诊断非酒精性脂肪性肝炎的非侵入性工具的临床断言语句的共识。
J Clin Gastroenterol. 2023 Mar 1;57(3):253-264. doi: 10.1097/MCG.0000000000001780.
8
Reduced and more appropriate referrals of patients with type 2 diabetes using liver stiffness measurement compared to FIB-4.与FIB-4相比，使用肝脏硬度测量法对2型糖尿病患者进行的转诊减少且更合适。
Ir J Med Sci. 2023 Apr;192(2):649-654. doi: 10.1007/s11845-022-03019-5. Epub 2022 Apr 29.
9
Metabolic Dysfunction-Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study.代谢功能障碍相关脂肪性肝病增加结直肠癌风险：一项全国性队列研究。
Clin Transl Gastroenterol. 2022 Jan 12;13(1):e00435. doi: 10.14309/ctg.0000000000000435.
10
Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease.马来西亚胃肠病学和肝脏病学会关于代谢功能障碍相关脂肪性肝病的共识声明。
J Gastroenterol Hepatol. 2022 May;37(5):795-811. doi: 10.1111/jgh.15787. Epub 2022 Feb 8.